section name header

Indications

REMS


Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

Interactions

Drug-drug:

Availability

(Generic available)

Route/Dosage

Hyperphosphatemia

Iron Deficiency Anemia

US Brand Names

Auryxia

Action

  • Binds phosphorous and precipitates it as ferric phosphate.
  • After being transported through enterocytes into the blood, oxidized ferric iron circulates bound to transferrin where it is incorporated into hemoglobin.
Therapeutic effects:
  • Maintenance of normal phosphorous levels.
  • Resolution of iron deficiency anemia.

Classifications

Therapeutic Classification: electrolyte modifiers

Pharmacologic Classification: phosphate binders

Pharmacokinetics

Absorption: Some absorption follows oral administration and may lead to iron overload.

Distribution: Unknown.

Metabolism/Excretion: Following binding, precipitated ferric phosphate is excreted in stool.

Half-Life: Unknown.

Time/Action Profile

(lowering of serum phosphorous)

ROUTEONSETPEAKDURATION
POwithin 1 wkunknownunknown



Patient/Family Teaching

Pronunciation

FE-rik SI-trate